Redmile Group, LLC, 10% Owner at Aprea Therapeutics, Inc. (APRE), bought 2,268,718 shares at $15.00 ($6.0M) on 2019-10-07, disclosed to the SEC on 2019-10-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,868,718 | $0 | 0.0% |
| 2 | $15.00 | 400,000 | $6.0M | 100.0% |
| Total | $2.64 avg | 2,268,718 | $6.0M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |